Original Contribution |
From the Departments of Pathology (K.O.Y., C.M.G., S.M.S.) and Molecular and Cellular Biology (K.O.Y.), University of Washington, Seattle, and Departments of Chemistry (M.M.R., S.T.L.) and Pathology and Laboratory Medicine (S.T.L.), University of North Carolina at Chapel Hill.
Correspondence to Karen O Yee, University of Washington, Box 357335, Seattle, WA 98195. E-mail y66409d{at}u.washington.edu
AbstractThe degree of lumen
narrowing in advanced lesions correlates poorly with the amount of
intimal mass accumulated in the atherosclerotic plaque. As an alternate
mechanism of stenosis, we propose that human smooth muscle
cells bind to fibrin deposited in the matrix and exert contractile
forces to cause a narrowing of the lumen. In the present study we
demonstrated in vitro that human newborn aortic smooth muscle cell
lines can contract and adhere to fibrin clots composed of either
fibronectin-depleted plasma ("plasma") or recombinant fibrin. By
using neutralizing antibodies and RGD peptides, we showed that members
of the integrin family mediated the interaction between human newborn
smooth muscle cells and fibrin. Neutralizing antibodies against the
integrin
vß3 (c7E3 Fab and LM609) did not inhibit either plasma
clot contraction or recombinant fibrin clot contraction by human
newborn smooth muscle cells. In contrast, antibodies against
5,
ß1, and
5ß1 inhibited contraction of clots composed of either
plasma or recombinant fibrin. Anti-
vß3, anti-
v, anti-
5,
anti-ß1, and anti-
5ß1 antibodies inhibited human newborn smooth
muscle cell adhesion to plasma clots; however, only anti-
5,
anti-ß1, and anti-
5ß1 antibodies significantly inhibited
adhesion to recombinant fibrin. While the linear RGD peptides had no
effect, the cyclic peptide penRGD inhibited adhesion to plasma clots
and recombinant fibrin. However, it did not block contraction of
recombinant fibrin clots. These results suggest that during the
interaction of human newborn smooth muscle cell lines with fibrin,
5ß1 plays a significant role. This interaction is of
potential interest as a target for efforts to block vascular
contraction.
Key Words: atherosclerosis remodeling stenosis thrombosis
This article has been cited by other articles:
![]() |
Z. Sun, L. A. Martinez-Lemus, M. A. Hill, and G. A. Meininger Extracellular matrix-specific focal adhesions in vascular smooth muscle produce mechanically active adhesion sites Am J Physiol Cell Physiol, July 1, 2008; 295(1): C268 - C278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cho, J. L. Degen, B. S. Coller, and D. F. Mosher Fibrin but Not Adsorbed Fibrinogen Supports Fibronectin Assembly by Spread Platelets: EFFECTS OF THE INTERACTION OF {alpha}IIb{beta}3 WITH THE C TERMINUS OF THE FIBRINOGEN {gamma}-CHAIN J. Biol. Chem., October 21, 2005; 280(42): 35490 - 35498. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Podolnikova, V. P. Yakubenko, G. L. Volkov, E. F. Plow, and T. P. Ugarova Identification of a Novel Binding Site for Platelet Integrins {alpha}IIb{beta}3 (GPIIbIIIa) and {alpha}5{beta}1 in the {gamma}C-domain of Fibrinogen J. Biol. Chem., August 22, 2003; 278(34): 32251 - 32258. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Moiseeva Adhesion receptors of vascular smooth muscle cells and their functions Cardiovasc Res, December 1, 2001; 52(3): 372 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Davenpeck, C. Marcinkiewicz, D. Wang, R. Niculescu, Y. Shi, J. L. Martin, and A. Zalewski Regional Differences in Integrin Expression : Role of {{alpha}}5{beta}1 in Regulating Smooth Muscle Cell Functions Circ. Res., February 16, 2001; 88(3): 352 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikari, K. Fujikawa, K. O. Yee, and S. M. Schwartz alpha 1-Proteinase Inhibitor, alpha 1-Antichymotrypsin, or alpha 2-Macroglobulin Is Required for Vascular Smooth Muscle Cell Spreading in Three-dimensional Fibrin Gel J. Biol. Chem., April 21, 2000; 275(17): 12799 - 12805. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Stringa, V Knauper, G Murphy, and J Gavrilovic Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells J. Cell Sci., January 6, 2000; 113(11): 2055 - 2064. [Abstract] [PDF] |
||||
![]() |
S. A. Corbett and J. E. Schwarzbauer Requirements for alpha 5beta 1 Integrin-mediated Retraction of Fibronectin-Fibrin Matrices J. Biol. Chem., July 23, 1999; 274(30): 20943 - 20948. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Coleman, G. A. Braden, M. C. Willingham, and D. C. Sane Vitaxin, a Humanized Monoclonal Antibody to the Vitronectin Receptor ({alpha}vß3), Reduces Neointimal Hyperplasia and Total Vessel Area After Balloon Injury in Hypercholesterolemic Rabbits Circ. Res., June 11, 1999; 84(11): 1268 - 1276. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |